Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (3) , 626-631
- https://doi.org/10.1373/clinchem.2003.026328
Abstract
Background: A new commercially available (so-called second-generation) IRMA for parathyroid hormone (PTH) separately detects intact PTH and its N-truncated fragments; however, no studies have compared the first- and second-generation IRMAs for PTH in patients with primary hyperparathyroidism (PHPT) to assess their respective diagnostic accuracies. Methods: We concomitantly investigated 39 postmenopausal patients with PHPT and a control group of 70 healthy postmenopausal women matched for age, renal function, and vitamin D status. In all individuals, PTH was measured with a classic IRMA (PTH-S; DiaSorin Inc.), which uses antibodies directed against epitopes 1–34 and 39–84, and a new method (Scantibodies Laboratory. Inc.), which uses antibodies against epitopes 1–4 and 39–84 (PTH-W) and epitopes 7–34 and 39–84 (PTH-T). We also assayed serum PTH in 10 PHPT patients every 24 h for 5 days after successful surgery. Results: The different assays gave serum PTH values that were >2 SD higher than values for the control population in 59% (PTH-S), 77% (PTH-W), and 82% (PTH-T) of patients with PHPT. However, ROC curve analysis showed no significant differences among the three PTH assays, demonstrating overlapping diagnostic sensitivities. In PHPT patients, the correlation among the assays was highly significant (r = 0.91–0.92; P <0.001). The ratio PTH-W:PTH-T × 100 showed a gaussian distribution in both PHPT patients and controls, whose mean (SD) values [63.4 (13.3)% vs 64.5 (9.5)%, respectively] did not differ significantly. After parathyroidectomy, the mean percentages of variation in PTH detected with all of the assays were quite similar. Conclusions: The distribution of the PTH-W:PTH-T ratio in patients and controls suggests that PHPT does not markedly influence the rate at which biologically inactive fragments are generated by central or peripheral cleavage of PTH. The similar postoperative curves seem to contradict the hypothesized effect of acute hypocalcemia in modulating the central secretion of hormonal fragments. Our results indicate that the three investigated assays have similar diagnostic sensitivities in PHPT.Keywords
This publication has 9 references indexed in Scilit:
- Influence of PTH assay methodology on differential diagnosis of renal bone diseaseNephrology Dialysis Transplantation, 2003
- PTH Metabolites in Renal Failure: Bioactivity and Clinical ImplicationsSeminars in Dialysis, 2002
- The evolution of assays for parathyroid hormoneCurrent Opinion in Nephrology and Hypertension, 2001
- Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid FunctionJournal of Bone and Mineral Research, 2001
- A novel mechanism for skeletal resistance in uremiaKidney International, 2000
- A Novel Immunoradiometric Assay Detects Full-Length Human PTH but not Amino-Terminally Truncated Fragments: Implications for PTH Measurements in Renal FailureJournal of Clinical Endocrinology & Metabolism, 1999
- Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patientsBritish Journal of Nutrition, 1999
- Recovery of Parathyroid Hormone Secretion After Parathyroid AdenomectomyJournal of Clinical Endocrinology & Metabolism, 1988
- Age-Related Changes in Serum Immunoreactive Parathyroid Hormone and its Biological Action in Healthy Men and Women*Journal of Clinical Endocrinology & Metabolism, 1987